Quantbot Technologies LP Pliant Therapeutics, Inc. Transaction History

Quantbot Technologies LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 09, 2024	BUY	$10.58 - $15.61 $158,530 - $233,900	14,984 Added 5409.39%	15,261 $164,000
Q1 2024 May 06, 2024	BUY	$14.14 - $19.59 $3,916 - $5,426	277 New	277 $4,000
Q3 2023 Nov 07, 2023	BUY	$14.58 - $20.15 $99,173 - $137,060	6,802 Added 26.23%	32,735 $567,000
Q2 2023 Aug 08, 2023	BUY	$18.12 - $30.56 $469,905 - $792,512	25,933 New	25,933 $469,000
Q2 2022 Aug 09, 2022	SELL	$4.11 - $8.75 $752 - $1,601	-183 Reduced 8.32%	2,017 $16,000
Q1 2022 May 16, 2022	BUY	$7.01 - $14.1 $15,422 - $31,020	2,200 New	2,200 $15,000

168

63.2M

245K

373K

Ticker PLRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 48,682,000
Market Cap $600M
Description
Pliant Therapeutics, Inc., a clinical stage biopharmaceutical company, discovers, develops, and commercializes novel therapies for the treatment of fibrosis and related diseases in the United States. Its lead product candidate is PLN-74809, an oral small-molecule dual selective inhibitor of avß6 and avß1 integrins, which is in three Phase 2a tri...

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

Stay updated on Quantbot Technologies LP with notifications on news.